Nuveen Asset Management, LLC Marker Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.88 - $3.56 $362,039 - $685,563	-192,574 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.47 - $3.29 $5,631 - $12,603	-3,831 Reduced 1.95%	192,574 $431,000
Q4 2020 Feb 16, 2021	SELL	$1.36 - $1.75 $1,011 - $1,302	-744 Reduced 0.38%	196,405 $285,000
Q3 2020 Nov 16, 2020	SELL	$1.5 - $2.2 $27,546 - $40,400	-18,364 Reduced 8.52%	197,149 $295,000
Q2 2020 Aug 14, 2020	BUY	$1.69 - $2.79 $207,800 - $343,055	122,959 Added 132.85%	215,513 $446,000
Q1 2020 May 14, 2020	BUY	$1.59 - $3.35 $35,997 - $75,844	22,640 Added 32.38%	92,554 $175,000
Q4 2019 Feb 14, 2020	BUY	$2.68 - $4.85 $1,921 - $3,477	717 Added 1.04%	69,914 $201,000
Q2 2019 Aug 15, 2019	BUY	$5.15 - $7.92 $356,364 - $548,040	69,197 New	69,197 $548,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $163M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.